Cancer Testing/Screening Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Cancer Testing and Cancer Screening Market
Cancer Testing/Screening Market: By Cancer Type (Lung, Blood, Bone, Others); By Technique (Imaging, Endoscopy, Molecular & Genomics Testing); By Stage (TNM, Prognostic Factors, Others); By Gender; By Geography - Forecast(2018-2023)
Report Code : HCR 0078
Updated Date: 16 October, 2018  
5

Copies sold

    Client Rating

1. Cancer Testing/Screening Market - Overview
1.1. Definitions and Scope
2. Cancer Testing/Screening Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Cancer Testing/Screening Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Cancer Testing/Screening Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Cancer Testing/Screening Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Cancer Testing/Screening Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Cancer Testing/Screening Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Cancer Testing/Screening Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Introduction 
8.3.2. Lung Cancer
8.3.3. Blood Cancer 
8.3.4. Bone Cancer
8.3.5. Gall Bladder Cancer
8.3.6. Testicular Cancer
8.3.7. Thyroid Cancer
    8.3.8. Kidney Cancer
    8.3.9. Liver Cancer
    8.3.10. Pancreatic Cancer
    8.3.11. Brain Cancer
8.3.12. Abdominal Cancer
8.3.13. Eye Cancer
8.3.14. Mouth Cancer
8.3.15. Breast Cancer
8.3.16. Cervix Cancer
8.3.17. Ovarian Cancer
8.3.18. Others
9. Cancer Testing/Screening Market – By Technique (Market Size -$Million / $Billion)
9.1. Introduction
9.2. Imaging Techniques
9.2.1. CT scan
9.2.2. MRI
9.2.3. X-ray
9.2.4. Nuclear
9.2.5. Ultrasound
9.2.6. Mammography
9.2.7. Others
9.3. Endoscopy procedure
9.3.1. Colonoscopy
9.3.2. Sigmoidoscopy
9.3.3. Others
9.4. Biopsy and cytology tests
9.4.1. Needle biopsy
9.4.2. CT-guided biopsy
9.4.3. Ultrasound-guided biopsy
9.4.4. Bone biopsy
9.4.5.Bone marrow biopsy
9.4.6.Liver biopsy
9.4.7.Kidney biopsy 
9.4.8. Aspiration biopsy
9.4.9. Prostate biopsy
9.4.10 Skin biopsy
9.4.11 Surgical biopsy
9.4.12 Others
9.5. Genomic and Molecular tests
9.5.1. Next Generation Sequencing (NGS)
9.5.2. RT- PCR
9.5.3. icroarray techniques
9.5.4. Biomarker testing
9.5.5. Others
10. Cancer Testing/Screening Market – By Stage (Market Size -$Million / $Billion)
10.1. TNM Stages
10.2. Stages 0,1,2,3,4
10.3. Prognostic Factors
10.4. Other Staging Systems
11. Cancer Testing/Screening Market – By Gender (Market Size -$Million / $Billion)
11.1. Men
11.1.1. New Born
11.1.2. Infant
11.1.3. Child
11.1.4. Adolescent
11.1.5. Adults
11.1.6. Seniors
11.2. Women
11.2.1. New Born
11.2.2. Infant
11.2.3. Child
11.2.4. Adolescent
11.2.5. Adults
11.2.6. Seniors
12. Cancer Testing/Screening - By Geography (Market Size -$Million / $Billion)
12.1. Cancer Testing/Screening Market - North America Segment Research
12.2. North America Market Research (Million / $Billion)
12.2.1. Segment type Size and Market Size Analysis 
12.2.2. Revenue and Trends
12.2.3. Application Revenue and Trends by type of Application
12.2.4. Company Revenue and Product Analysis
12.2.5. North America Product type and Application Market Size
12.2.5.1. U.S.
12.2.5.2. Canada 
12.2.5.3. Mexico 
12.2.5.4. Rest of North America
12.3. Cancer Testing/Screening - South America Segment Research
12.4. South America Market Research (Market Size -$Million / $Billion)
12.4.1. Segment type Size and Market Size Analysis 
12.4.2. Revenue and Trends
12.4.3. Application Revenue and Trends by type of Application
12.4.4. Company Revenue and Product Analysis
12.4.5. South America Product type and Application Market Size
12.4.5.1. Brazil  
12.4.5.2. Venezuela
12.4.5.3. Argentina
12.4.5.4. Ecuador
12.4.5.5. Peru
12.4.5.6. Colombia 
12.4.5.7. Costa Rica
12.4.5.8. Rest of South America
12.5. Cancer Testing/Screening - Europe Segment Research
12.6. Europe Market Research (Market Size -$Million / $Billion)
12.6.1. Segment type Size and Market Size Analysis 
12.6.2. Revenue and Trends
12.6.3. Application Revenue and Trends by type of Application
12.6.4. Company Revenue and Product Analysis
12.6.5. Europe Segment Product type and Application Market Size
12.6.5.1. U.K  
12.6.5.2. Germany 
12.6.5.3. Italy 
12.6.5.4. France
12.6.5.5. Netherlands
12.6.5.6. Belgium
12.6.5.7. Spain
12.6.5.8. Denmark
12.6.5.9. Rest of Europe
12.7. Cancer Testing/Screening – APAC Segment Research
12.8. APAC Market Research (Market Size -$Million / $Billion)
12.8.1. Segment type Size and Market Size Analysis 
12.8.2. Revenue and Trends
12.8.3. Application Revenue and Trends by type of Application
12.8.4. Company Revenue and Product Analysis
12.8.5. APAC Segment – Product type and Application Market Size
12.8.5.1. China 
12.8.5.2. Australia
12.8.5.3. Japan 
12.8.5.4. South Korea
12.8.5.5. India
12.8.5.6. Taiwan
12.8.5.7. Malaysia
13. Cancer Testing/Screening Market - Entropy
13.1. New product launches
13.2. M&A's, collaborations, JVs and partnerships
14. Cancer Testing/Screening Market – Industry / Segment Competition landscape
14.1. Market Share Analysis
14.1.1. Market Share by Country- Top companies
14.1.2. Market Share by Region- Top 10 companies
14.1.3. Market Share by type of Application – Top 10 companies
14.1.4. Market Share by type of Product / Product category- Top 10 companies
14.1.5. Market Share at global level- Top 10 companies
14.1.6. Best Practises for companies
15. Cancer Testing/Screening Market – Key Company List by Country
16. Cancer Testing/Screening Market Company Analysis
16.1. Market Share, Company Revenue, Products, M&A, Developments
16.2. Dias Orin S.P.A
16.3. Epigenetics Ag
16.4. Techlab
16.5. Positive Bioscience
16.6. Genextropy Inc.
16.7. M Genomics Ltd
16.8. 20/20 GeneSystems, Inc.
16.9. AB SCIEX
16.10. Abbott Laboratories
16.11. Abcodia Ltd.
16.12. Company 11
16.13. Company 12
16.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
17. Cancer Testing/Screening Market -Appendix
17.1. Abbreviations
17.2. Sources
18. Cancer Testing/Screening Market -Methodology
18.1. Research Methodology
18.1.1. Company Expert Interviews
18.1.2. Industry Databases
18.1.3. Associations
18.1.4. Company News
18.1.5. Company Annual Reports
18.1.6. Application Trends
18.1.7. New Products and Product database
18.1.8. Company Transcripts
18.1.9. R&D Trends
18.1.10. Key Opinion Leaders Interviews
18.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll